Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

ADVANCED CELL & GENE THERAPY LLC

UEI: WL5TMYA1RLD7CAGE: 7MEC3

ADVANCED CELL & GENE THERAPY LLC is a federal contractor, registered under UEI WL5TMYA1RLD7 and CAGE code 7MEC3. It has been awarded $12,900 in federal contracts. Primary work spans Other Scientific and Technical Consulting Services. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

WL5TMYA1RLD7

CAGE Code

7MEC3

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

541690Other Scientific and Technical Consulting Services(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ADVANCED CELL & GENE THERAPY LLC specializes in advanced biotechnological research and development focused on cell and gene therapy platforms, leveraging cutting-edge molecular biology, vector engineering, and translational science to support preclinical and clinical-stage therapeutic innovation. Th...

ADVANCED CELL & GENE THERAPY LLC specializes in advanced biotechnological research and development focused on cell and gene therapy platforms, leveraging cutting-edge molecular biology, vector engineering, and translational science to support preclinical and clinical-stage therapeutic innovation. The company’s core capabilities include viral vector design and manufacturing, ex vivo cell engineering, gene editing workflows using CRISPR and base-editing technologies, and process development for GMP-compliant cell therapy production. Their technical expertise extends to analytical characterization of therapeutic candidates, including flow cytometry, qPCR, NGS, and potency assays, with a focus on scalability and regulatory readiness for FDA submission. A key differentiator is their integrated approach to bridging academic discovery with industrial-scale application, emphasizing process robustness and patient-specific therapeutic optimization. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal collaboration can be inferred. The absence of recent award data precludes identification of primary federal partners or programmatic focus areas. The company operates under NAICS 541690, which encompasses other scientific and technical consulting services, indicating a service-based model centered on R&D support rather than product commercialization. In practice, this suggests they provide specialized contract research services to government-funded biomedical programs, academic institutions, or biopharma collaborators engaged in regenerative medicine and personalized therapeutics. ADVANCED CELL & GENE THERAPY LLC is a small business structured as a 2L entity, headquartered in Chapel Hill, North Carolina, a region known for its concentration of biotech research and academic medical centers. The company holds no government certifications, positioning it as a nimble, privately operated research services provider focused on innovation in advanced therapy modalities. Its geographic presence aligns with the Triangle’s life sciences ecosystem, facilitating collaboration with NIH-funded labs and clinical trial networks.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ADVANCED CELL & GENE THERAPY LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ADVANCED CELL & GENE THERAPY LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ADVANCED CELL & GENE THERAPY LLC's top NAICS codes and agencies

NAICS: 541690
New
International
Study of Global Navigation Satellite Systems Disruption in the Energy Sector [Étude sur les perturbations des systèmes mondiaux de satellites de navigation, dans le secteur de l’énergie]
Solicitation # WS5980553072
Public Services and Procurement Canada, on behalf of Natural Resources Canada, is soliciting proposals for a comprehensive study to assess the Canadian energy sector's dependence on Global Navigation Satellite Systems (GNSS). The project aims to identify the impacts of potential disruptions to Positioning, Navigation, and Timing (PNT) data, specifically accounting for regional differences in energy infrastructure and regulatory frameworks. The successful contractor will generate research, analytical products, and stakeholder guidance to develop mitigation strategies and resilience solutions. All final deliverables must be submitted by March 31, 2027, with the performance period divided into two phases: an initial 25-week period followed by a subsequent 16-week period. Bids must be submitted via the SAP Business Network by December 14, 2026, at 2 pm EST. The contract will be awarded based on a weighted evaluation consisting of 70% technical merit and 30% price. Proposals must be organized into three distinct sections: a Technical Offer, a Financial Offer, and a Submission/Declaration Form. The project is classified as unclassified, though the contractor must maintain strict confidentiality of all client information and adhere to Canadian law. Evaluation of the work will be conducted by the government, with the right to inspect deliverables at the contractor's facilities, and the contractor is required to maintain accurate inspection records for three years following the contract's conclusion.
Government of Canada / Gouvernement du Canada

POSTED

about 13 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 541690
New
International
Actuarial Costing and Return on Investment Analysis for the Modernization of the Federal Workers’ Compensation Regime
Solicitation # 100032367
The Department of Employment and Social Development for the Government of Canada is seeking an independent actuarial costing analysis to evaluate the direct and indirect costs of the federal workers compensation regime. The objective is to compare the costs of maintaining the current regime against two proposed modernization options, including a return on investment analysis. This study will focus on overall regime costs, the five federal employers with the highest claim volumes, and a selection of employers with moderate claim volumes. The contract has a maximum funding ceiling of 750,000.00 CAD and a performance period extending 12 months after the award. The project is divided into three key milestones: a Progress Report due March 31, 2027, a Draft Report and Presentation due ten months after award, and a Final Report due twelve months after award. Payment is structured as 25 percent for the first two deliverables and 50 percent for the final report. To be eligible, the lead resource must be a Fellow of the Canadian Institute of Actuaries. Selection is based on the highest rated bid within budget, requiring a minimum technical score of 71 out of 100 points. All deliverables must be submitted in English and adhere to ETSI EN 301 549 accessibility standards.
Department of Employment and Social Development

POSTED

1 day ago

DEADLINE

in 16 days
View Details
NAICS: 541690
New
International
Public Art Consulting Services - Collection Assessment
Solicitation # 235817
The City of North Vancouver is seeking a qualified professional to conduct a Public Art Collection Assessment for approximately 100 indoor and outdoor artworks located across parks, plazas, municipal buildings, and commercial developments. The scope of work includes providing individual condition reports for each piece—categorized by ratings such as Excellent, Good, Fair, Poor, or Deaccession—along with photographs, treatment recommendations based on best practices, and cost estimates for repairs. Additionally, the consultant will provide guidance on cultural protocol and safety regarding Indigenous artworks and develop a documentation framework for future additions to the collection. Proposals will be evaluated by a selection committee based on the qualifications of key personnel (30%), previous projects and references (20%), fees and disbursements (15%), project plan and methodology (15%), cultural competency (15%), and sustainability (5%). Applicants must submit a single PDF file by December 3, 2026, and must include a signed Proponent Commitment Form to avoid rejection. The successful contractor is required to maintain a Commercial General Liability policy of at least 5 million Canadian dollars and comply with various Canadian and British Columbia labor and human rights legislations. All financial transactions will be conducted in Canadian dollars, with invoicing requiring a detailed breakdown of hours per team member.
City of North Vancouver

POSTED

1 day ago

DEADLINE

in 27 days
View Details